Mayflower Financial Advisors’s Avalo Therapeutics AVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3	Closed	-$5K	–	341
2022 Q2	$5K	Hold	3	–	–	﹤0.01%	335
2022 Q1	$7K	Hold	3	–	–	﹤0.01%	363
2021 Q4	$17K	Buy	+3	New	+$17K	﹤0.01%	349